In ophthalmic pharmacotherapy, the cornea is considered to be a major pathway for ocular permeation of topically applied drugs.
On the other hand, several transporters are expressed in ocular tissue. Jain-Vakkalagadda et al. identified an active transport system for L-arginine on rabbit corneal epithelium and human cornea and showed that amino acid ester prodrugs of acyclovir appeared to be substrates for this transporter. 7) Sodium dependent nucleoside transporter was functionally expressed on the rabbit cornea although acyclovir and idoxuridine were not substrates for this transporter. 8) We previously demonstrated an expression of P-glycoprotein (P-gp) on cultured normal rabbit corneal epithelial cells (RCEC). 9) Dey et al. reported that P-gp restricts topical erythromycin absorption across the cornea, which can be inhibited by known P-gp inhibitors. 10) There was a relationship between the permeability of beta-blockers, which are often used in ophthalmic therapy, through an excised rabbit cornea and their lipophilicities. 6, 11) Among them, however, permeability of acebutolol was much lower than that expected by its lipophilicity. This results indicated the possibility that acebutolol was secreted by specific transporter in corneal epithelium.
Therefore, in the present study, the permeation mechanism of acebutolol in the corneal epithelium is investigated by RCEC system that we previously establised. 12) 
MATERIALS AND METHODS

Materials and Animals
Acebutolol, FITC-dextran (FD-4, molecular weight 4400), 6-carboxyfluorescein (6-CF) were purchased from Sigma Chemicals (St. Louis, MO, U.S.A.). Cyclosporin A (CyA) was kindly supplied from Sandoz Pharmaceuticals (Basel, Switzerland). Sodium azide (NaN 3 ) and verapamil hydrochloride (VER) were obtained from Nacalai Tesque Inc. (Kyoto, Japan). All other chemicals were commercial products of reagent grade.
Primary cultured cells were obtained from Kurabo Industries Ltd. (Osaka, Japan). Transwell-COL ® cell culture chambers (pore size 0.4 mm, diameter 12 mm, surface area 1 cm 2 ) were purchased from Costar (Bedford, MA, U.S.A.). Dulbecco's modified Eagle's medium/nutrient mixture F-12 (DMEM/F-12), fetal bovine serum (FBS) and another culture reagents were purchased from GIBCO (Grand Island, NY, U.S.A.). Epidermal growth factor (EGF), choleratoxin (CTX), hydrocortisone (HCS), and insulin-transferrin sodium selenite media supplement (ISL) were purchased from Sigma Chemicals. Penicillin G and streptomycin were obtained from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Human fibronectin was purchased from Boehringer Mannheim GmbH (Mannheim, Germany). 14 C-Mannitol (specific activity, 2.11 GBq/mmol) was purchased from Amersham Life Science (Buckinghamshire, U.K.).
Male Nippon albino rabbits (Kitayama Labes, Ltd. Japan: 1.5-2.5 kg) were used in the permeability experiment through an excised rabbit cornea. They were housed in cages in an air-conditioned room and maintained on a standard laboratory diet (ORC4, Oriental Yeast Co. Ltd., Tokyo, Japan). The rabbits were fasted for 24 h before use but had free access to water. All experiments in the present study conformed to Guideline for Animal Experimentation in Nagasaki University.
Cell Culture RCEC were cultured according to an ordinary method reported previously. 12) RCEC were grown using DMEM/F-12 at pH 7.4. The culture medium was supplemented with 5% FBS, 10 ng/ml EGF, 100 ng/ml CTX, 5 mg/ ml ISL, 500 ng/ml HCS, and the antibiotics (penicillin G 100 IU/mlϩstreptomycin 100 mg/ml). Transwell-COL ® insert was pre-coated with 4.0 mg human fibronectin as the attachment factor at room temperature for 30 min. RCEC were seeded at a density of 4ϫ10 4 cells/cm 2 on filter membrane of Transwell-COL ® insert and cultured at 37°C under 95% air and 5% CO 2 . The barrier of RCEC layer grown on the filter membrane was assessed by measuring the transepithelial electrical resistance (TEER) with a Millicell ERS electrical resistance meter (Millipore, Bedford, MA, U.S.A.).
Permeability Study Using RCEC In permeability study, RCEC grown on a filter membrane were washed three times with Hank's balanced salt solution (HBSS) (1.3 mM CaCl 2 , 5.0 mM KCl, 0.3 mM KH 2 PO 4 , 0.8 mM MgCl 2 , 138 mM NaCl, 0.3 mM Na 2 HPO 4 , 5.6 mM D-glucose, and 10 mM HEPES for pH 7.4) and preincubated for 30 min at 37°C in a 5% CO 2 atmosphere before permeability experiments.
Drug permeability from apical side to basal side (A-to-B) was initiated by removing all of HBSS in apical side (0.5 ml) and being replaced with HBSS containing various concentrations of drugs at 37°C. At 30, 60, 90, and 120 min, sample (0.9 ml) was collected from the basal side (1.5 ml) and was replaced with equal volume of HBSS. Drug permeability from basal side to apical side (B-to-A) was also initiated by being replaced with drug solution in basal side and sample (0.3 ml) was collected from the apical side at 37°C. The integrity of the cell layer was checked at the beginning and at the end of the permeability experiments by determination of the TEER. The collected samples were supplied for drug determination with a high performance liquid chromatography (HPLC). Hydrophilic compounds such as 14 C-mannitol (1.85 KBq), 6-CF (50 mM), and FD-4 (50 mM) were also used as penetrants. Drug permeability through filter membrane without cell layer was examined in the same manner.
In permeability study with inhibitors, the cell layer was preincubated with inhibitors in both apical and basal sides for 30 min. The inhibitor was also present in both sides during the experiment. Sodium azide (NaN 3 , 10 mM), verapamil hydrochloride (VER, 200 mM), and cyclosporin A (CyA, 30 mM) were used as inhibitors.
Calculation of Transcellular Permeability Coefficient The apparent permeability coefficient through overall membrane (P app , cm/s) was calculated from a slope (flux, nmol/h) of drug amount profile in receiver side (P app ϭslope/3600/surface area of the layer/initial concentration in the donor side).
The permeability coefficient of drugs through filter membrane (P filt ) was obtained from the drug flux through the fibronectin-coated filter membrane. The permeability coefficient of drugs through the RCEC layer (P cell ) was calculated by Eq. 1.
Further, the P cell includes the permeability coefficients via transcellular route (P transcell ) and paracellular route (P paracell ).
The P transcell was calculated by subtracting P paracell from P cell . The P paracell of acebutolol was calculated from an inverse relationship between the P cell and square root of the molecular weight in hydrophilic compounds. Permeability Study Using an Excised Rabbit Cornea Rabbits were sacrificed with an injection of sodium pentobarbital into a marginal ear vein. The cornea was dissected and mounted in the Ussing chamber. HBSS solutions (4 ml) were added to the epithelial side and the endothelial side, respectively. The bathing solutions were bubbled with 5% CO 2 in air to maintain the pH at 7.4 and to provide adequate agitation of the solution. The Ussing chamber assembly was maintained at 37°C by a water jacket, using a circulating water bath. After 30 min incubation, permeability was initiated by removing 0.4 ml of HBSS in epithelial side and being replaced with HBSS containing 1 mM acebutolol with or without 500 mM VER. At 15, 30, 45, 60, 90, and 120 min, aliquots (0.2 ml) were sampled from the endothelial side and replaced with the equal volume of HBSS. Acebutolol in the samples was assayed with an HPLC system. The apparent permeability coefficient through excised cornea (P app , cm/s) was calculated from a slope (flux, nmol/h) of drug amount profile in receiver side (P app ϭslope/3600/surface area of the layer/initial concentration in the donor side).
Drug Determination The samples of 14 C-mannitol were measured by using a liquid scintillation counter (Tri-Carb ® Models 2100TR, Packard Co., Meriden, CT, U.S.A.). The samples of 6-CF and FD-4 were assayed by a spectrofluorophotometer (FP-770, JASCO Corporation, Tokyo, Japan; excitation and emission wavelengths; 492 and 524 nm for 6-CF; 495 and 514 nm for FD-4).
At in vitro permeability study, samples of acebutolol (0.3 ml) were mixed with methanol (0.6 ml) including internal standard (0.05 mM phenacetin). The mixture was centrifuged at 12000 g for 10 min and 50 ml of supernatant was injected into an HPLC system (LC-10AD, Shimadzu Co., Ltd., Kyoto, Japan) used in a reverse-phase mode. A stationary phase used was Cosmosil 5C 18 -MS packed column (150 mm lengthϫ4.6 mm i.d., Nacalai Tesque Inc., Kyoto, Japan). Mixtures of acetonitrile and 10 mM KH 2 PO 4 (85 : 15 v/v) were used as a mobile phase with a flow rate of 1.0 ml/ min. Acebutolol was monitored with a UV spectrophotometric detector (240 nm).
Samples of acebutolol in permeability experiment through an excised rabbit cornea were assayed with another HPLC system (GULLIVER ® : JASCO Corporation, Tokyo, Japan) used in a reverse-phase mode. A stationary phase used was Inertsil ODS-3V column (250 mm lengthϫ4.6 mm i.d., GL Sciences, Tokyo, Japan). Mixtures of methanol and 50 mM NaH 2 PO 4 (43 : 57 v/v) were used as a mobile phase with a flow rate of 1.0 ml/min. Retention of acebutolol was monitored with a UV spectrophotometric detector (254 nm).
RESULTS
Using DMEM/F-12 containing 5% FBS, supplemented with EGF, CTX, ISL, and HCS, RCEC were readily attached to the matrix and began to spread. The density of seeding was 4ϫ10 4 cells/cm 2 and led to rapid confluence. When allowed to become highly postconfluent, the cells became very tightly packed, and stratify on the surface of the membrane. The cells grew multilayer and had high transparency. The TEER increased to a maximum (143.8Ϯ23.3 ohmϫcm 2 ) around day 8 after inoculation. Cultured cells appeared to be more closely approximating in vivo corneal tissue in morphology.
There was an inverse linear relationship between square root values of molecular weight and P cell values in hy-drophilic drugs. The P paracell of acebutolol was calculated from the inverse relationship and the P transcell was determined by subtracting P paracell from P cell . The permeation profiles of acebutolol in the A-to-B direction at various concentrations (5-5000 mM) are shown in Fig. 1A . The P transcell values of acebutolol were calculated from these profiles and are presented in Fig. 1B . The P transcell values of acebutolol significantly increased with an increase of drug concentrations. Figure 2 shows the P transcell values of acebutolol (5, 50 mM) in different directions. The P transcell values of acebutolol in the A-to-B direction was smaller than that of opposite direction (B-to-A) at 5 and 50 mM. Figure 3 shows the effects of inhibitors on the transcellular permeability of acebutolol (50 mM) in the A-to-B direction. NaN 3 , VER, and CyA enhanced the P transcell values of acebutolol. Figure 4 shows the effect of VER on permeability of acebutolol using an excised rabbit cornea. Measurable lag time in permeation profile of acebutolol was observed (Fig. 4A) . VER significantly enhanced the corneal permeability coefficient, P app , of acebutolol through an excised cornea as shown in Fig. 4B .
DISCUSSION
The corneal epithelium consists of 5-6 cell layers of nonkeratinized squamous cells. The epithelium consists of a basal layer of columnar cells, 2-3 layer of wing cells, and 1 or 2 outermost layers of squamous, polygonal-shaped superficial cells.
13) The outer layer of the surface cells possess microvilli on their anterior surface that presumably help to anchor the precorneal tear film. The stratified corneal epithelium acts both as a protective barrier to prevent invasion of foreign substances. RCEC were well-developed microplicae and were multilayered. 12) Their cytoplasmic morphology and desmosomes were analogous to the in vivo situation.
Transcellular drug permeation was calculated by subtracting the paracellular permeation. Despite the leakiness of our model system, it is still appropriate system for evaluating transcellular drug permeability. In fact, the P transcell value of acebutolol (1.88ϫ10 Ϫ6 cm/s) was almost agreed with its permeability coefficients (1.10ϫ10 Ϫ6 cm/s) through an excised cornea reported previously. 6) This agreement indicates that acebutolol predominantly permeate via transcellular route across excised tight cornea.
The epithelial permeability of acebutolol was directionand concentration-dependent, indicating the special secretion from basolateral side to apical side (Figs. 1, 2) . The acebutolol permeability in the A-to-B direction was increased by metabolic inhibitor, NaN 3 (Fig. 3) . However, the timolol and tilisolol permeability in the A-to-B direction was not increased by NaN 3 in the preliminary experiment. These results showed that active transporter mediated permeability of acebutolol in the B-to-A direction. This results is agreement with the previous report that acebutolol's permeability coefficient through a rabbit excised cornea was much lower than expected by its lipophilicity.
10) P-gp, one of ATP binding cassette (ABC) transporter, is well-known drug efflux pump and is expressed in various tissues. 14, 15) We previously demonstrated that P-gp appears to be located on cultured rabbit corneal epithelial cells using CyA as P-gp substrate. 7) Dey et al. 16) reported that cornea and corneal epithelial cells expresses the functionally active P-gp efflux pump using CyA and Rhodamin-123 as P-gp substrates. In Fig. 3 , CyA and VER, which were transported by P-gp, significantly increased the permeability of acebutolol in the A-to-B direction, suggesting the contribution of P-gp to active secretion of acebutolol in corneal epithelium. VER also enhanced the permeability of acebutolol from epithelial side to endothelial side through an excised cornea as shown in Fig. 4 . There was a relationship between the permeability of beta-blockers through an excised rabbit cornea and their lipophilicities. 6, 11) Among them, however, permeability of acebutolol was much lower than that expected by its lipophilicity. This results indicated the possibility that acebutolol was secreted by specific transporter in corneal epithelium.
Thus, acebutolol was suggested to be actively secreted via P-gp in a corneal epithelium. The lower permeability of acebutolol through cornea and conjunctiva than that expected by its lipophilicity was considered to be caused by this secretion transporter. P-gp may play a role of protective barrier on foreign substances. RCEC system is also useful to characterize the drug permeation mechanism through corneal epithelium.
